NNO donor Schiff base metal complexes: Enzyme mimicking, DNA binding and biological insights

Abstract

The present work focuses on the microwave-assisted synthesis, characterization and biological applications of a novel tridentate NNO donor Schiff base ligand derived from the condensation of 4-(Diethylamino)salicylaldehyde and 4,5-Dimethyl-1,2-phenylenediamine, along with its transition metal complexes of Cu(II) and Co(II) in 1:1 and 1:2 ratios each respectively. A theoretical basis for comprehending the electronic framework and characteristics of the complexes has been studied through the use of a computational approach. Further, the distorted octahedral geometry of the Schiff base metal complexes is confirmed by using analytical methods such as elemental analysis, molar conductance, ESI-MS, UV–Vis, FTIR, TGA and NMR spectra, which confirmed that NNO donor site of the ligand is coordinated with the metal ions. The complexes have been screened for their potential application as a catalyst for the catalytic conversion of 3,5-di‑tert‑butyl‑catechol (3,5-DTBC) to 3,5-di‑tert-butylquinone (3,5-DTBQ) and the turnover numbers (Kcat) have been found in the range 36.46–43.05 h−1 in methanol. Absorption spectroscopic technique has been employed to examine the possible modalities of interactions with the synthesized complexes using CT-DNA and the related binding constants exhibited in the range 2.58 × 104 M−1 to 1.98 × 105 M−1 thus depicting appreciable binding affinity. To evaluate the bioactivities, in-vitro assays for anti-oxidant and anti-inflammatory activity have also been implemented. The Cu(II) complex (CuL) has significant anti-oxidant activity and the Co(II) complex (CoL) has superior anti-inflammatory activity compared to all other complexes with IC50 values of 238.78 µM and 140.25 µM respectively. To better understand the molecular-level interactions and identify probable binding energies of inhibitors, molecular docking simulations have been performed.